ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Key Considerations When Filling Dual Chamber Syringes

  Dual-chamber syringes (DCSs) are in high demand across the pharmaceutical and hospital industries. Learn about the challenges of the DCS filling manufacturing market and how to overcome them.

• Applying Automation To The Manufacture Of Drug Delivery Devices

  Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

• Small-Scale Aseptic Filling Technology Considerations

  Small-scale aseptic filling presents a unique set of challenges. Learn what to look for when evaluating small-scale aseptic filling technology.

• How Various Clinical Study Stages Influence Oral Formulation Approach

  It’s important for pharmaceutical and biopharmaceutical companies to implement a phase-appropriate approach for early formulation development and later-stage commercial development.

• Pediatric Patient Considerations During Dose Development

  Specific dosing guidelines and acceptable dosage forms for pediatric patients need to be developed to optimize therapeutic efficacy and limit and prevent serious adverse side effects.

• Making A Case For A Fixed Dose Combination Drug Strategy

  As patient-centricity spurs innovation in drug delivery systems, examine the potential of FDCs to provide convenient dosing and how increased patient compliance is alleviating the cost of health care.

• Capsule Formulation Development: From Dosage Forms To Filling

  Capsules are tasteless and easy to take, offer streamlined development timelines, and simplicity of manufacturing. Discover capsule formulation development and the benefits of capsule dosage forms.

• Masking Bitter Drug Taste In Pediatric Formulations With Microcaps

  The challenge was developing a taste masked, convenient dosage formulation of a very bitter API for patients two-years old and older undergoing treatment of HIV infection.

• FAQs On The Revised EU GMP Annex 1: Volume 3

  The EU GMP Annex 1 revision, effective August 2023, requires a detailed Contamination Control Strategy. Learn how it impacts global manufacturers, RABS use, and personnel procedures.

• An Elegant Solution For Delivery Of Acid Sensitive Pharmaceuticals

  Sustained release drug delivery products offer effective therapies in the treatment of serious chronic diseases, and their development requires customized solutions with tunable material properties.